On Sept. 20, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a final rule on the Medicare Drug Rebate Program (MDRP). Access the Regulatory NewsBREAK to learn more.

Get quick answers to some of the most common questions on GLP-1 therapies. Get quick answers to some of the most common questions on GLP-1 therapies. Explore how these treatments fit into managed care pharmacy and the nuances of managing this class.

On Sept. 13, 2024, the Internal Revenue Service (IRS), Employee Benefits Security Administration (EBSA), and Centers for Medicare & Medicaid Services (CMS) (collectively, the Departments) released a Final Rule on Requirements Related to the Mental Health Parity and Addiction Equity Act (Final Rule). The Final Rule will be published in the Federal Register on Sept. 23, 2024. Access the Regulatory NewsBREAK to learn more.

On Sept. 13, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a memorandum on Reporting Routing Values for the Medicare Prescription Payment Plan (M3P). Access the Regulatory NewsBREAK to learn more.

SB 966, California's PBM reform bill, could reshape pharmacy benefit manager regulation if signed into law. Governor Newsom’s decision is expected by September 30.

AMCP Comments on Medicare CY 2025. Physician Fee Schedule On July 31, CMS unveiled a proposed rule covering the CY 2025 Physician Fee Schedule, changes to Part B payment and coverage policies, and the Medicare Prescription Drug Inflation Rebate program, among other policies.